Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entity is an uncharacterized *antisense transcript* located at the C6orf89 locus on chromosome 6 (Ensembl: ENSG00000298791)[7]. It does not code for protein and is annotated as a long non-coding RNA (lncRNA); there are no functional data, publications, or experimental studies describing its biological or disease relevance. Standard databases (Ensembl, NCBI, UniProt) list only its sequence and locus; there is no information supporting its activity, disease association, or role as a drug target. Its canonical related gene, C6orf89, encodes a protein (Chromosome 6 open reading frame 89, also known as bombesin receptor‐activated protein) involved in chromatin remodeling, epithelial proliferation, and wound healing[1][3][11][13][15]. However, this antisense entry (ENSG00000298791) itself is not validated or described as a target, receptor, enzyme, or marker in current biomedical literature or databases. Summary: This is most likely a technical annotation for an uncharacterized, presumably non-coding RNA at the C6orf89 locus. It is not a therapeutic target, is missing biological information, and should not be considered equivalent to the protein or canonical function associated with C6orf89. The entry is primarily useful for gene structure annotation, not for structured biomedical ontology or drug development[7][9][15].
Not applicable (no drug or experimental data)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to Chromosome 6 open reading frame 89 (ENSG00000298791).